Your Health, We Care

Home >Drug List>Pacritinib>Indications of Pacritinib

Pacritinib(LuciPac)

Release date: 2026-01-05 13:59:46     Recommended: 82

It is indicated for the treatment of adult patients with intermediate- or high-risk primary or secondary myelofibrosis and a platelet count of less than 50 × 10⁹/L.